DeepMed Research

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

BMS-986353

Generic Name: BMS-986353

Overview

No overview information available.

Background

No background information available.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)

Phase 1

Recruiting

Posted: 2024/01/23

Sponsor:

Juno Therapeutics, I...

A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1)

Phase 1

Recruiting

Posted: 2023/05/23

Sponsor:

Juno Therapeutics, I...

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

CAR-T Therapy Shows Promise in Autoimmune Diseases with Minimal Toxicities

6 months ago

A phase 1/2 study of CD19 CAR-T therapy in autoimmune diseases, including lupus, myositis, and systemic sclerosis, demonstrates significant clinical responses.

CAR-T Therapy Shows Promise in Refractory Autoimmune Diseases

6 months ago

Early clinical studies, including the CASTLE basket study, demonstrate the potential of CD19-directed CAR-T therapy in treating severe, refractory autoimmune diseases.

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy